Literature DB >> 6446455

Combined effects of methotrexate and 5-fluoropyrimidine on human breast cancer cells in serum-free culture.

R C Donehower, J C Allegra, M E Lippman, B A Chabner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6446455     DOI： 10.1016/0014-2964(80)90206-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.

Authors:  R A Sorace; C S Bagley; A S Lichter; D N Danforth; M W Wesley; R C Young; M E Lippman
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

2.  A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer.

Authors:  J C Allegra; T M Woodcock; S P Richman; K I Bland; J L Wittliff
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.